Patents by Inventor Klaus Stöhr

Klaus Stöhr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines for protecting against influenza
    Patent number: H2283
    Abstract: A vaccine containing a H1 subtype influenza A virus hemagglutinin is either unadjuvanted or is adjuvanted but not with an oil-in-water emulsion adjuvant. The vaccine is suitable for immunizing a patient against swine flu. The vaccine may be monovalent. The vaccine may include two different H1 subtype influenza A virus hemagglutinins, wherein (i) the first H1 subtype influenza A virus hemagglutinin is more closely related to SEQ ID NO: 1 than to SEQ ID NO: 3 and (ii) the second H1 subtype influenza A virus hemagglutinin is more closely related to SEQ ID NO: 3 than to SEQ ID NO: 1. A monovalent vaccine may be administered in conjunction with a trivalent A/H1N1-A/H3N2 B seasonal influenza vaccine. Other embodiments are also disclosed, such as reassortant viruses.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: September 3, 2013
    Assignee: Novartis AG
    Inventors: Klaus Stöhr, Philip Dormitzer, Giuseppe Del Giudice
  • Vaccines for protecting against influenza
    Patent number: H2284
    Abstract: A live attenuated influenza vaccine contains a H1 subtype influenza A strain. Its hemagglutinin is more closely related to SEQ ID NO: 1 than to SEQ ID NO: 3.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: September 3, 2013
    Assignee: Novartis AG
    Inventors: Klaus Stöhr, Philip Ralph Dormitzer, Michael Broeker